BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 6295008)

  • 1. The biology of circulating B lymphocytes infected with Epstein-Barr virus during infectious mononucleosis.
    Robinson JE
    Yale J Biol Med; 1982; 55(3-4):311-6. PubMed ID: 6295008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.
    Klein E; Masucci MG
    Springer Semin Immunopathol; 1982; 5(1):63-73. PubMed ID: 6314570
    [No Abstract]   [Full Text] [Related]  

  • 3. Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation.
    Lewin N; Aman P; Akerlund B; Gustavsson E; Carenfelt C; Lejdeborn L; Klein G; Klein E
    Immunol Lett; 1990 Oct; 26(1):59-65. PubMed ID: 2177451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis.
    Al Tabaa Y; Tuaillon E; Jeziorski E; Ouedraogo DE; Bolloré K; Rubbo PA; Foulongne V; Rodière M; Vendrell JP
    J Clin Virol; 2011 Sep; 52(1):33-7. PubMed ID: 21684200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro.
    Sugden B
    Rev Infect Dis; 1982; 4(5):1048-61. PubMed ID: 6293034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
    Klein E; Ernberg I; Masucci MG; Szigeti R; Wu YT; Masucci G; Svedmyr E
    Cancer Res; 1981 Nov; 41(11 Pt 1):4210-5. PubMed ID: 6272964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.
    Strang G; Rickinson AB
    Immunology; 1987 Dec; 62(4):647-54. PubMed ID: 2828228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis.
    Robinson J; Smith D; Niederman J
    Nature; 1980 Sep; 287(5780):334-5. PubMed ID: 6252472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr (EB) virus genome-containing, EB nuclear antigen-negative B-lymphocyte populations in blood in acute infectious mononucleosis.
    Crawford DH; Rickinson AB; Finerty S; Epstein MA
    J Gen Virol; 1978 Mar; 38(3):449-60. PubMed ID: 204732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G; Rickinson AB
    Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune surveillance against Epstein-Barr virus.
    Moss DJ; Burrows SR; Khanna R; Misko IS; Sculley TB
    Semin Immunol; 1992 Apr; 4(2):97-104. PubMed ID: 1377517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of tinidazole on primary EBV infection and immunocompetence.
    Marklund G; Ernberg I; Britton S; Lundberg C
    Scand J Infect Dis; 1984; 16(1):17-23. PubMed ID: 6320359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmacytic differentiation of circulating Epstein-Barr virus-infected B lymphocytes during acute infectious mononucleosis.
    Robinson JE; Smith D; Niederman J
    J Exp Med; 1981 Feb; 153(2):235-44. PubMed ID: 6264016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing faces of EBV research.
    Klein G; Klein E
    Prog Med Virol; 1984; 30():87-106. PubMed ID: 6087416
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis.
    Tosato G; Magrath I; Koski I; Dooley N; Blaese M
    N Engl J Med; 1979 Nov; 301(21):1133-7. PubMed ID: 226884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M; Myc A; Matej H; Rudzka L
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis.
    Royston I; Sullivan JL; Periman PO; Perlin E
    N Engl J Med; 1975 Dec; 293(23):1159-63. PubMed ID: 171568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cells under influence: transformation of B cells by Epstein-Barr virus.
    Küppers R
    Nat Rev Immunol; 2003 Oct; 3(10):801-12. PubMed ID: 14523386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis.
    Wang F; Blaese RM; Zoon KC; Tosato G
    J Clin Invest; 1987 Jan; 79(1):7-14. PubMed ID: 3025263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.